IPDD WG 1 member, Macromolecular Drugs –Antibodies, LINXS Fellow

Dr. Karoline Bechtold-Peters studied Pharmacy at the Ludwig-Maximilians-University of Munich and received her PhD in Pharmaceutical Technology in 1994 from Professor Dr. Karl Thomas with a thesis on "Stabilization of enzyme activity and availability of pancreatin pellets during aqueous coating with enteric-resistant cellulose derivatives". She started in 1949 at Boehringer Ingelheim Pharma KG as Laboratory Manager for solid forms and inhalation powders, then moved to Pharmaceutical Biotechnology in 2000 as Head of Biologics Formulation Development (dosage forms for proteins, DNA and peptides including stand-by analytics via DSC, HP-SEC, DVS, particle sizing, BIAcore and other methods). In 2003, she was appointed Associate Director, Clinical Supplies and Process Transfer, Biopharmaceuticals. In 2011, Dr. Bechtold-Peters moved to F. Hoffmann-La Roche in Basel as Head Clinical Manufacturing Parenterals, Process Science & Business Excellence / Pharma Technical Development PTDE, Global Biologics and in 2016 to Novartis Pharma AG, also in Basel. There she is Senior Strategy and Technology Leader, BioFuture, and since 2021 in the Scientific Office Drug Product Development OneBiologics. Dr. Bechtold-Peters' interests lie particularly in protein formulation and biopharmaceutical manufacturing. She has developed expertise in the interaction of biologics with interfaces such as packaging materials and in the freezing and thawing of protein preparations. She has co-authored more than 45 papers and more than 30 patents.